Lorence Kim, M.D.
Lorence Kim joined TRV as a venture partner in 2020. He was previously the Chief Financial Officer of Moderna, guiding $4.4 billion of capital raising to support the company’s platform efforts in mRNA medicines and the discovery and development of a pipeline of 20+ candidates across infectious disease, oncology, rare disease and autoimmune disease. Prior to Moderna, Lorence spent 14 years at Goldman Sachs, where his last role was the co-head of the US biotech banking practice. Lorence previously served on the board of directors of Seres Therapeutics. Lorence lives with his wife and three children in New York City.
- A.B., Biochemical Sciences, Harvard University
- M.D., University of Pennsylvania School of Medicine
- MBA, Healthcare Management, The Wharton School of the University of Pennsylvania
- East Coast